Microbiologics acquires SensID, expanding expertise in diagnostic quality controls
Microbiologics, announced the acquisition of SensID.
Founded in 2015, SensID is based in Rostock, Germany where they will continue operations post-acquisition, marking Microbiologics' first location outside the United States.
The combined expertise of Microbiologics and SensID will empower both companies to deliver a broader portfolio of quality control solutions to further support diagnostic technology developers and healthcare.
SensID specializes in providing intensely characterized reference materials and quality controls used for R&D, validation, and quality control of molecular diagnostic tests. They recently launched the first ESR1 mutations reference set for validation of cell-free DNA mutation detection methods, as well as a platform-agnostic control for dihydropyrimidine dehydrogenase (DPYD, DHP, DPD, DHPDHASE) testing. The integration of SensID's expertise will complement Microbiologics' comprehensive offerings.
As the integration progresses, the partnership will not disrupt the companies’ ongoing partnerships and projects. The collaboration will combine Microbiologics' infectious disease diagnostic solutions and SensID's molecular oncology expertise.
